Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 661 AL 675

Case report of rapid onset cognitive and functional decline: Diagnosis of sporadic Creutzfeldt–Jakob disease

Guo B, Ho T, Potamianos R.

Aust J Gen Pract. 2018 Mar;47(3):127-128. doi: 10.31128/AFP-08-17-4313.

ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's Disease

Chen W, Jin F, Cao G, Mei R, Wang Y, Long P, Wang X, Ge W.

Curr Drug Targets. 2018;19(9):1038-1044. doi: 10.2174/1389450119666180406112050.

Development of a risk score for the prediction of incident dementia in older adults using a frailty index and health checkup data: The JAGES longitudinal study

Lin HR, Tsuji T, Kondo K, Imanaka Y.

Prev Med. 2018 Jul;112:88-96. doi: 10.1016/j.ypmed.2018.04.004. Epub 2018 Apr 4.

White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis

van den Berg E, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP.

J Alzheimers Dis. 2018;63(2):515-527. doi: 10.3233/JAD-170573.

Brain Metabolic, Structural, and Behavioral Pattern Learning for Early Predictive Diagnosis of Alzheimer's Disease

Mandal PK, Shukla D.

J Alzheimers Dis. 2018;63(3):935-939. doi: 10.3233/JAD-180063.

Caring for patients with dementia in the acute care setting

Butcher L.

Br J Nurs. 2018 Apr 12;27(7):358-362. doi: 10.12968/bjon.2018.27.7.358.

Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis

Kongpakwattana K, Sawangjit R, Tawankanjanachot I, Bell JS, Hilmer SN, Chaiyakunapruk N.

Br J Clin Pharmacol. 2018 Jul;84(7):1445-1456. doi: 10.1111/bcp.13604. Epub 2018 May 14.

Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study

Neergaard JS, Dragsbæk K, Christiansen C, Karsdal MA, Brix S, Henriksen K.

PLoS One. 2018 Apr 11;13(4):e0194802. doi: 10.1371/journal.pone.0194802. eCollection 2018.

Incremental Validity of Montreal Cognitive Assessment Index Scores in Mild Cognitive Impairment and Alzheimer Disease

Goldstein FC, Milloy A, Loring DW; for the Alzheimer’s Disease Neuroimaging Initiative.

Dement Geriatr Cogn Disord. 2018;45(1-2):49-55. doi: 10.1159/000487131. Epub 2018 Apr 11.

Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis

Chu CS, Tseng PT, Stubbs B, Chen TY, Tang CH, Li DJ, Yang WC, Chen YW, Wu CK, Veronese N, Carvalho AF, Fernandes BS, Herrmann N, Lin PY.

Sci Rep. 2018 Apr 11;8(1):5804. doi: 10.1038/s41598-018-24248-8.

Olfactory Dysfunction as a Global Biomarker for Sniffing out Alzheimer's Disease: A Meta-Analysis

Kotecha AM, Corrêa ADC, Fisher KM, Rushworth JV.

Biosensors (Basel). 2018 Apr 13;8(2):41. doi: 10.3390/bios8020041.

Brain complications of diabetes mellitus: a cross-sectional study of awareness among individuals with diabetes and the general population in Ireland

Dolan C, Glynn R, Griffin S, Conroy C, Loftus C, Wiehe PC, Healy ML, Lawlor B.

Diabet Med. 2018 Jul;35(7):871-879. doi: 10.1111/dme.13639. Epub 2018 May 2.

EEG-based neurophysiological indicators of hallucinations in Alzheimer's disease: Comparison with dementia with Lewy bodies

Dauwan M, Linszen MMJ, Lemstra AW, Scheltens P, Stam CJ, Sommer IE.

Neurobiol Aging. 2018 Jul;67:75-83. doi: 10.1016/j.neurobiolaging.2018.03.013. Epub 2018 Mar 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias